Genzyme spinout X4 Pharmaceuticals lays out clinical plan
The company's CXCR4 inhibitors work to modulate the tumor microenvironment - improving the efficacy of the immune system in fighting cancer.
The company's CXCR4 inhibitors work to modulate the tumor microenvironment - improving the efficacy of the immune system in fighting cancer.